PHRX

Pharmagen, Inc. Stock Price

OTCPK:PHRX Community·US$517.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PHRX Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

PHRX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Pharmagen, Inc. Key Details

US$4.4m

Revenue

US$1.7m

Cost of Revenue

US$2.7m

Gross Profit

US$9.2m

Other Expenses

-US$6.4m

Earnings

Last Reported Earnings
Mar 31, 2014
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About PHRX

Founded
n/a
Employees
n/a
CEO
n/a
Website
n/a

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.

Recent PHRX News & Updates

No updates

Recent updates

No updates